Clarity Medical Group Holding Limited provided consolidated earnings guidance for the year ended March 31, 2022. For the period, the profit attributable to owners of the Company is expected to record a drop from approximately HKD 35.8 million for the year ended 31 March 2021 to not less than approximately HKD 13.0 million for the year ended 31 March 2022, representing an expected drop of approximately 63.7%.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.495 HKD | -1.00% | -4.81% | -21.43% |
29/05 | Clarity Medical Group Holding Limited Appoints Cheng Jessica as Independent Non-Executive Director and Audit Committee | CI |
24/05 | Clarity Medical to Widen Loss in Fiscal 2024 | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-21.43% | 33.43M | |
-23.39% | 15.56B | |
-2.70% | 11.65B | |
+2.65% | 11.58B | |
+2.37% | 10.06B | |
-10.45% | 7.16B | |
+8.05% | 6.85B | |
-4.29% | 5.71B | |
+13.33% | 4.3B | |
-3.96% | 4.3B |
- Stock Market
- Equities
- 1406 Stock
- News Clarity Medical Group Holding Limited
- Clarity Medical Group Holding Limited Provides Consolidated Guidance for the Year Ended March 31, 2022